Radiation dose ≥54 Gy and CA 19-9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation.
about
Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancerIntensity modulated radiotherapy as neoadjuvant chemoradiation for the treatment of patients with locally advanced pancreatic cancer. Outcome analysis and comparison with a 3D-treated patient cohort.Development and validation of automatic tools for interactive recurrence analysis in radiation therapy: optimization of treatment algorithms for locally advanced pancreatic cancer.Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.
P2860
Radiation dose ≥54 Gy and CA 19-9 response are associated with improved survival for unresectable, non-metastatic pancreatic cancer treated with chemoradiation.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Radiation dose ≥54 Gy and CA 1 ...... r treated with chemoradiation.
@ast
Radiation dose ≥54 Gy and CA 1 ...... r treated with chemoradiation.
@en
type
label
Radiation dose ≥54 Gy and CA 1 ...... r treated with chemoradiation.
@ast
Radiation dose ≥54 Gy and CA 1 ...... r treated with chemoradiation.
@en
prefLabel
Radiation dose ≥54 Gy and CA 1 ...... r treated with chemoradiation.
@ast
Radiation dose ≥54 Gy and CA 1 ...... r treated with chemoradiation.
@en
P2093
P2860
P356
P1433
P1476
Radiation dose ≥54 Gy and CA 1 ...... r treated with chemoradiation.
@en
P2093
Bruce D Minsky
Caroline J Novak
Daniel W Golden
Stanley L Liauw
P2860
P2888
P356
10.1186/1748-717X-7-156
P577
2012-09-13T00:00:00Z
P5875
P6179
1013784022